Alprostadil liposomal - Yipinhong Pharmaceutical
Alternative Names: Alprostadil liposomes for injectionLatest Information Update: 31 Oct 2021
Price :
$50 *
At a glance
- Originator Yipinhong Pharmaceutical
- Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Arteriosclerosis obliterans
Most Recent Events
- 30 Nov 2020 No development reported - Phase-II for Arteriosclerosis obliterans in China (Injection)
- 01 Aug 2016 Phase-II clinical trials in Arteriosclerosis obliterans in China (Injection) (NCT02877173)